Busiswa Dyan

Busiswa Dyan

Auto-generated profile, based on publicly available information

Busiswa Dyan


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
PMPhumlane Mdluli
Phumlane Mdluli
TMTintswalo Mgwenya
Tintswalo Mgwenya
BDBusiswa Dyan
Busiswa Dyan
NSNdivhuwo Shumbula
Ndivhuwo Shumbula
NMNosipho Moloto
Nosipho Moloto
MMMbuso Mlambo
Mbuso Mlambo
This study reports on the optimization of Malaria RDTs, targeting histidine-rich protein-2 (HRP-2) in human blood samples. Gold nanoparticles (AuNPs) bioconjugates prepared using monoclonal antibodies PTL3, 4H48 and IB47 were synthesized, characterized, and employed as colourimetric markers/reporters. The conjugates were tested against detector antibodies (CH1-13, 4H46 and DH60), which were immobilized as test lines using WHO-approved positive samples from multiple geographic areas (Nigeria, Santa Lucia, Benin, Philippine and the United States of America). All AuNP bioconjugates exhibited high stability, with an average gold particle size of 40 nm. Amongst the tested conjugates, AuNPs bioconjugates of PTL3-CH3 pair combination resulted in high intensity of both test and control lines. Further optimisation of the PTL3 conjugate across pH 7.5, 8.5, and 9.5 revealed that pH 9.5 produced the highest chromaticity-derived intensity values. This chromaticity-guided optimisation strategy enables objective colour quantification and offers a robust framework for improving RDT performance and quality control.